Literature DB >> 30065357

Landmarks in prostate cancer.

Niranjan J Sathianathen1,2,3, Badrinath R Konety4, Juanita Crook5, Fred Saad6, Nathan Lawrentschuk7,8.   

Abstract

The field of prostate cancer has been the subject of extensive research that has resulted in important discoveries and shaped our appreciation of this disease and its management. Advances in our understanding of the epidemiology, natural history, anatomy, detection, diagnosis, grading, staging, imaging, and management of prostate cancer have changed clinical practice and influenced guideline recommendations. The development of the Gleason score and subsequent modifications enabled accurate prediction of prognosis. Increased anatomical understanding and improved surgical techniques resulted in the development of nerve-sparing surgery for radical prostatectomy. The advent of active surveillance has changed the management of low-risk disease, and chemotherapy and hormonal therapy have improved the outcomes of patients with distant disease. Ongoing research and clinical trials are expected to yield more practice-changing results in the near future.

Entities:  

Mesh:

Year:  2018        PMID: 30065357     DOI: 10.1038/s41585-018-0060-7

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


  24 in total

1.  Soluble Endoglin (sCD105) as a Novel Biomarker for Detecting Aggressive Prostate Cancer.

Authors:  Adriana C Vidal; Frank Duong; Lauren E Howard; Emily Wiggins; Stephen J Freedland; Neil A Bhowmick; Jun Gong
Journal:  Anticancer Res       Date:  2020-03       Impact factor: 2.480

Review 2.  The potential of cell-free and exosomal microRNAs as biomarkers in liquid biopsy in patients with prostate cancer.

Authors:  Monyse de Nóbrega; Mariana Bisarro Dos Reis; Érica Romão Pereira; Marilesia Ferreira de Souza; Ilce Mara de Syllos Cólus
Journal:  J Cancer Res Clin Oncol       Date:  2022-08-04       Impact factor: 4.322

3.  Using deep learning to detect patients at risk for prostate cancer despite benign biopsies.

Authors:  Bojing Liu; Yinxi Wang; Philippe Weitz; Johan Lindberg; Johan Hartman; Wanzhong Wang; Lars Egevad; Henrik Grönberg; Martin Eklund; Mattias Rantalainen
Journal:  iScience       Date:  2022-06-23

4.  Interactions Between Tumor Biology and Targeted Nanoplatforms for Imaging Applications.

Authors:  Mehdi Azizi; Hassan Dianat-Moghadam; Roya Salehi; Masoud Farshbaf; Disha Iyengar; Samaresh Sau; Arun K Iyer; Hadi Valizadeh; Mohammad Mehrmohammadi; Michael R Hamblin
Journal:  Adv Funct Mater       Date:  2020-03-03       Impact factor: 18.808

Review 5.  Considering the role of radical prostatectomy in 21st century prostate cancer care.

Authors:  Anthony J Costello
Journal:  Nat Rev Urol       Date:  2020-02-21       Impact factor: 14.432

6.  Tumor B7-H3 expression in diagnostic biopsy specimens and survival in patients with metastatic prostate cancer.

Authors:  Gulanbar Amori; Emiko Sugawara; Yasuyuki Shigematsu; Masashi Akiya; Junko Kunieda; Takeshi Yuasa; Shinya Yamamoto; Junji Yonese; Kengo Takeuchi; Kentaro Inamura
Journal:  Prostate Cancer Prostatic Dis       Date:  2021-02-08       Impact factor: 5.554

7.  Exploration on Gleason score variation trend of patients with prostate carcinoma from 1996 to 2019: a retrospective single center study.

Authors:  Weiyu Zhang; Gongwei Wang; Fengling Lan; Huanrui Wang; Danhua Shen; Kexin Xu; Tao Xu; Hao Hu
Journal:  Gland Surg       Date:  2021-02

Review 8.  The potential of CAR T cell therapy for prostate cancer.

Authors:  Philipp Wolf; Jamal Alzubi; Christian Gratzke; Toni Cathomen
Journal:  Nat Rev Urol       Date:  2021-07-08       Impact factor: 14.432

9.  Urinary exosome microRNA signatures as a noninvasive prognostic biomarker for prostate cancer.

Authors:  Sun Shin; Yong Hyun Park; Seung-Hyun Jung; Sun-Hee Jang; Mee Young Kim; Ji Youl Lee; Yeun-Jun Chung
Journal:  NPJ Genom Med       Date:  2021-06-11       Impact factor: 8.617

10.  Consulting "Dr. Google" for Prostate Cancer Treatment Options: A Contemporary Worldwide Trend Analysis.

Authors:  Giovanni E Cacciamani; Silvia Bassi; Marco Sebben; Anna Marcer; Giorgio I Russo; Andrea Cocci; Paolo Dell'Oglio; Luis G Medina; Nima Nassiri; Alessandro Tafuri; Andre Abreu; Antonio B Porcaro; Alberto Briganti; Francesco Montorsi; Inderbir S Gill; Walter Artibani
Journal:  Eur Urol Oncol       Date:  2019-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.